Related Experiment Video
Updated: Sep 29, 2025
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.9K
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
Pauline Gilson1, Jean-Louis Merlin1, Alexandre Harlé1
1Service de Biologie Moléculaire des Tumeurs, Institut de Cancérologie de Lorraine, CNRS UMR 7039 CRAN-Université de Lorraine, 6 Avenue de Bourgogne CS 30519, 54519 Vandœuvre-lès-Nancy, France.
Cancers
|March 25, 2022
Summary
Human cancers exhibit significant intra-tumour heterogeneity (ITH), meaning cells within a single tumor differ greatly. This diversity impacts treatment decisions and patient outcomes, necessitating new approaches to understand and manage cancer evolution.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Human solid tumors display significant cellular diversity (heterogeneity) at multiple levels.
- Inter-tumour heterogeneity between patients exceeds current classifications.
- Intra-tumour heterogeneity (ITH) describes cell-to-cell variation within a single tumor, evolving over time.
Purpose of the Study:
- To explore the extent and mechanisms of intra-tumour heterogeneity (ITH) in human cancers.
- To summarize the clinical implications of ITH in cancer patient management.
- To discuss current technological approaches for studying ITH.
Main Methods:
- Literature review focusing on intra-tumour heterogeneity.
- Analysis of mechanisms driving cancer cell diversity.
- Synthesis of clinical impacts and technological advancements.
Main Results:
- Tumour heterogeneity is a complex biological phenomenon, with ITH being a major contributor.
- ITH arises from various mechanisms and significantly impacts cancer progression.
- Current treatment strategies often overlook the dynamic nature of ITH.
Conclusions:
- Understanding ITH is crucial for effective cancer management.
- Advanced technologies are needed to fully characterize and address ITH.
- Future research should focus on integrating ITH insights into personalized cancer therapies.
